Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endouble 2: SRT + Envafolimab + Endostar in Advanced NSCLC
NCT07818304Phase 2Not yet recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- Oct 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
A Phase 2 trial of envafolimab, endostar in non-small cell lung cancer (NSCLC), sponsored by First People's Hospital of Lianyungang City. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
envafolimabendostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07818304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07818304.